Search

everythinglearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

miR-182 may help treat hallux valgus by targeting FGF9.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.

Trichohyalin, a hair follicle protein, has a part with repeating patterns of 23 amino acids.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

The gene KAP22-1 affects wool yield and fiber shape in sheep.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

Keratin 14 is uniquely found in a specific group of placental cells.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

A new gene, JMJD1C, may affect testosterone levels in men.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

CaBP1 and CaBP2 are important for maintaining hearing by supporting continuous calcium currents and nerve signaling in the ear.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Compound 4 is a promising treatment for hair loss with low toxicity.

TMPRSS6 is crucial for controlling hepcidin and normal iron absorption.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.